MEDCYN: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MEDCYN
Largest movements
- Cash +€28,971
up €28,971 (+51.2%), from €56,544 to €85,515
mainly Deferred charges and accrued income (+€23,392) and Net result for the year (+€17,379)
- Deferred charges and accrued income -€23,392
down €23,392 (-53.9%), from €43,430 to €20,038
- Receivables within one year +€8,855
new in 2025: €8,855
- Profit (loss) carried forward +€17,379
up €17,379 (+31.0%), from €56,005 to €73,383
- Tax, wage and social debts +€7,783
up €7,783 (+28.6%), from €27,259 to €35,042
of which Remuneration and social security: +€32,542
- Trade debts -€7,712
down €7,712 (-72.6%), from €10,629 to €2,917
- Other debts -€3,017
no longer reported in 2025 (was €3,017)
- Gross operating margin -€37,862
down €37,862 (-55.0%), from €68,789 to €30,927
- Taxes -€7,426
down €7,426 (-39.4%), from €18,866 to €11,441
- Other operating charges +€1,999
up €1,999 (+573.7%), from €348 to €2,348
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €99,974 | €114,409 | +€14,435 | +14.4% |
| Current assets | 29/58 | €99,974 | €114,409 | +€14,435 | +14.4% |
| Amounts receivable within one year | 40/41 | - | €8,855 | +€8,855 | |
| Other amounts receivable | 41 | - | €8,855 | +€8,855 | |
| Cash at bank and in hand | 54/58 | €56,544 | €85,515 | +€28,971 | +51.2% |
| Deferred charges and accrued income | 490/1 | €43,430 | €20,038 | -€23,392 | -53.9% |
| Total equity and liabilities | 10/49 | €99,974 | €114,409 | +€14,435 | +14.4% |
| Equity | 10/15 | €59,005 | €76,383 | +€17,379 | +29.5% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €56,005 | €73,383 | +€17,379 | +31.0% |
| Amounts payable | 17/49 | €40,969 | €38,026 | -€2,944 | -7.2% |
| Amounts payable within one year | 42/48 | €40,905 | €37,959 | -€2,947 | -7.2% |
| Trade debts | 44 | €10,629 | €2,917 | -€7,712 | -72.6% |
| Suppliers | 440/4 | €10,629 | €2,917 | -€7,712 | -72.6% |
| Taxes, remuneration and social security | 45 | €27,259 | €35,042 | +€7,783 | +28.6% |
| Taxes | 450/3 | €24,759 | - | -€24,759 | |
| Remuneration and social security | 454/9 | €2,500 | €35,042 | +€32,542 | +1301.7% |
| Other amounts payable | 47/48 | €3,017 | - | -€3,017 | |
| Accrued charges and deferred income | 492/3 | €64 | €67 | +€3 | +5.0% |
| Other operating charges | 640/8 | €348 | €2,348 | +€1,999 | +573.7% |
| Gross operating margin | 9900 | €68,789 | €30,927 | -€37,862 | -55.0% |
| Operating profit (loss) | 9901 | €68,440 | €28,579 | -€39,861 | -58.2% |
| Financial income | 75/76B | €87 | €373 | +€286 | +329.4% |
| Recurring financial income | 75 | €87 | €373 | +€286 | +329.4% |
| Financial charges | 65/66B | €29 | €133 | +€104 | +357.9% |
| Recurring financial charges | 65 | €29 | €133 | +€104 | +357.9% |
| Profit (loss) for the period before taxes | 9903 | €68,498 | €28,819 | -€39,679 | -57.9% |
| Income taxes | 67/77 | €18,866 | €11,441 | -€7,426 | -39.4% |
| Profit (loss) for the period | 9904 | €49,632 | €17,379 | -€32,253 | -65.0% |
| Profit (loss) for the period to be appropriated | 9905 | €49,632 | €17,379 | -€32,253 | -65.0% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 7 October 2026 via checked.be.